Cargando…
Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis
This study was designed to evaluate the efficacy and safety of cytokine-induced killer (CIK) cell-based immunotherapy as an adjuvant therapy for hepatocellular carcinoma (HCC). Published studies were identified by searching Medline, Cochrane, EMBASE, and Google Scholar databases with the keywords: c...
Autores principales: | Yu, Ruili, Yang, Bo, Chi, Xiaohua, Cai, Lili, Liu, Cui, Yang, Lei, Wang, Xueyan, He, Peifeng, Lu, Xuechun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364004/ https://www.ncbi.nlm.nih.gov/pubmed/28360510 http://dx.doi.org/10.2147/DDDT.S124399 |
Ejemplares similares
-
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
por: Lee, Jeong-Hoon, et al.
Publicado: (2018) -
Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection
por: Pan, Qiu-Zhong, et al.
Publicado: (2020) -
Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies
por: Yang, Yang, et al.
Publicado: (2021) -
A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma
por: Pan, Qiu-Zhong, et al.
Publicado: (2015) -
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
por: Shi, Liangrong, et al.
Publicado: (2012)